EMCDDA Home
  • EN
Search

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium3.43.72.01.53.02.05.62.32889
Bulgaria4.8:2.30.5:0.01.51.0207
Czech Republic 2.17.01.40.15.09.03.1:985
Denmark2.15.92.42.0:2.03.73.81638
Germany3.36.92.60.63.80.76.62.014406
Estonia(1)2.9:0.7:::::157
Ireland2.66.13.21.5:1.85.81.52154
Greece5.99.6:2.2::4.60.31563
Spain(2)4.76.04.41.55.224.55.42.422856
France3.03.84.11.43.63.17.84.39633
Italy4.49.63.12.10.8:9.81.730631
Cyprus5.27.4:0.5::8.5:284
Latvia4.0:2.71.3:3.012.4:473
Lithuania:::::::::
Luxembourg :::::::::
Hungary(3)3.73.43.42.3::9.62.42738
Malta(4)7.84.1::::8.63.0246
Netherlands(5)4.54.82.40.82.33.03.51.15691
Austria2.65.03.01.6::4.2:1474
Poland(6)5.68.52.80.6:3.35.41.0834.0
Portugal6.54.16.01.14.05.58.35.35178
Romania(7)4.911.00.0:4.02.0::447
Slovenia4.12.0:2.0::4.9:370
Slovakia2.65.02.91.0:11.011.8:374
Finland1.8:1.510.0::3.3:201
Sweden1.74.21.71.03.0:4.72.0969
United Kingdom 2.73.61.61.32.31.73.33.641979
Croatia4.62.97.00.3::6.62.61201
Turkey:::::::::
Norway:::::::::
Total3.55.62.21.22.52.45.32.93.6
Total base485393703965252988518448504743047149578

Notes:

 : Indicates no data are available                     

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Data refer to outpatient and inpatient agencies. For Cannabis 6 males have been reported. 

 (2) Data refer to 2008 and to outpatient and prison centres (aggregated data). 

 (3) For Hallucinogens 6 males have been reported and for Volatile substances 10 males have been reported.                     

 (4) Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).                     

 (5) Data refer to outpatient, inpatient and low-threshold agencies (aggregated data). 

 (6) Data refers to 2008.                     

 (7) For Cannabis 57 males have been reported.                     

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 30 June 2011